Robert Leeth
Psychiatric/Mental Health · Coeur D Alene, IDNPI 1881657237
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,479 of the $4,321 with a category attached, or 80.5%. 19 manufacturers reported payments, led by Neuronetics, Inc. at 26.1% of the total. 2025 is the largest year on record at $3,002, more than ten times the $25 reported in 2021. Among psychiatric/mental health clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 156 payments — averaging $27.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$821
- Johnson & Johnson$372
- Otsuka America Pharmaceutical, Inc.$359
- Teva Pharmaceuticals USA, Inc.$318
- Lundbeck LLC$201
- plus $1K from 13 others
What the payments were for
- Travel & lodging$78318%
- Food & beverage$3,47981%
- Education$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 3 | $1,126 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 44 | $821 |
| Johnson & Johnson | 8 | $372 |
| Otsuka America Pharmaceutical, Inc. | 18 | $359 |
| Teva Pharmaceuticals USA, Inc. | 13 | $318 |
| Lundbeck LLC | 11 | $201 |
| Alkermes, Inc. | 10 | $198 |
| Axsome Therapeutics, Inc. | 11 | $165 |
| AbbVie | 8 | $160 |
| Sunovion Pharmaceuticals Inc. | 7 | $111 |
| Neurocrine Biosciences, Inc. | 4 | $90 |
| Vanda Pharmaceuticals Inc. | 5 | $89 |
| Supernus Pharmaceuticals, Inc. | 2 | $80 |
| Corium, LLC | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Pfizer | 2 | $32 |
| Ironshore Pharmaceuticals Inc. | 1 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$1,126
- INVEGA SUSTENNA$139
- CAPLYTA$124
How this compares
$4,321 in reported general payments places this provider in the 90th percentile of 221 psychiatric/mental health providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 13 | $43,005 |
| Aripiprazole | 16 | $2,221 |
| Vilazodone Hcl | 15 | $1,370 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 15 | $753 |
| Methylphenidate Hcl | 20 | $562 |
| Duloxetine Hcl | 15 | $370 |
| WaterWater For Irrigation,sterile | 11 | $246 |
| Trazodone Hcl | 35 | $220 |
| Zaleplon | 12 | $141 |
| Metoprolol Succinate | 11 | $54 |
| Alprazolam | 15 | $27 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $372 | $43,00513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 221 psychiatric/mental health providers in Idaho.
Other psychiatric/mental health in Coeur D Alene
- Jared PetrickCoeur D Alene$32K
- Peter GourleyCoeur D Alene$5K
- Zachary HarmanCoeur D Alene$2K
- Regina PrindleCoeur D Alene$2K
- Janet GourleyCoeur D Alene$2K
- Jason MartinIdaho Falls$78K
- Misti NewsonBoise$56K
- Carey CrillBoise$19K
- Deborah RushMeridian$13K
- Ashley CroftCaldwell$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.